Drug Type Small molecule drug |
Synonyms KM 819, KR-33493 |
Target |
Mechanism FAF1 inhibitors(FAS-associated factor 1 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Start Date27 Feb 2023 |
Sponsor / Collaborator |
Start Date19 Jul 2022 |
Sponsor / Collaborator |
Start Date01 Nov 2016 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple System Atrophy | Phase 2 | KR | 27 Feb 2023 | |
Parkinson Disease | Phase 1 | KR | 01 Nov 2016 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |